𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

✍ Scribed by Einsele, H; Hebart, H; Kauffmann-Schneider, C; Sinzger, C; Jahn, G; Bader, P; Klingebiel, T; Dietz, K; Löffler, J; Bokemeyer, C

Book ID
110012458
Publisher
Nature Publishing Group
Year
2000
Tongue
English
Weight
74 KB
Volume
25
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitation of cytomegalovirus (CMV) DN
Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy
✍ Karine Gourlain; Dominique Salmon; Elyanne Gault; Catherine Leport; Christine Ka 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract In HIV‐infected patients treated with highly active antiretroviral therapy (HAART) included in the Predivir cohort, we have evaluated the usefulness of CMV DNA quantitation by a TaqMan^®^ PCR assay from peripheral blood leukocytes (PBLs) to predict CMV disease occurrence. In parallel wi

Risk factors for ovarian failure in pati
Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy
✍ Chi Chiu Mok; Chak Sing Lau; Raymond Woon Sing Wong 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 772 KB

## Objective: To determine the incidence of ovarian failure after cyclophosphamide (cyc) treatment for systemic lupus erythematosus (sle) and to identify the risk factors for this complication. ## Methods: The records of 70 premenopausal female sle patients treated with cyc were reviewed retrospe